Table 2.
Characteristics | Crossover Comparison | |||
---|---|---|---|---|
Placebo (n = 62) | Resveratrol (n = 62) | Treatment Difference (Resveratrol–Placebo) |
p-Value | |
Raw number of hormonal migraines per phase | 1.03 ± 0.13 | 1.07 ± 0.14 | 0.032 ± 0.177 | 0.917 |
Hormonal migraine burden index | 0.56 ± 0.09 | 0.56 ± 0.09 | −0.003 ± 0.099 | 0.895 |
Wilcoxon Signed-Rank Test used for all comparisons.